Ogresta Doris, Mrzljak Anna, Cigrovski Berkovic Maja, Bilic-Curcic Ines, Stojsavljevic-Shapeski Sanja, Virovic-Jukic Lucija
Department of Gastroenterology and Hepatology, Sestre Milosrdnice University Hospital Center, Zagreb, Croatia.
Department of Gastroenterology and Hepatology, University Hospital Center Zagreb, Zagreb, Croatia.
J Clin Transl Hepatol. 2022 Apr 28;10(2):339-355. doi: 10.14218/JCTH.2021.00268. Epub 2022 Jan 12.
Non-alcoholic fatty liver disease (NAFLD) is closely related to insulin resistance, type 2 diabetes mellitus and obesity. It is considered a multisystem disease and there is a strong association with cardiovascular disease and arterial hypertension, which interfere with changes in the coagulation system. Coagulation disorders are common in patients with hepatic impairment and are dependent on the degree of liver damage. Through a review of the literature, we consider and discuss possible disorders in the coagulation cascade and fibrinolysis, endothelial dysfunction and platelet abnormalities in patients with NAFLD.
非酒精性脂肪性肝病(NAFLD)与胰岛素抵抗、2型糖尿病和肥胖密切相关。它被认为是一种多系统疾病,与心血管疾病和动脉高血压有很强的关联,这些疾病会干扰凝血系统的变化。凝血障碍在肝功能损害患者中很常见,并且取决于肝损伤的程度。通过文献综述,我们思考并讨论了NAFLD患者凝血级联反应和纤维蛋白溶解、内皮功能障碍及血小板异常方面可能存在的紊乱情况。